-
Signature
-
/s/ Katherine A. Krebel, Attorney-in-Fact
-
Issuer symbol
-
DRS
-
Transactions as of
-
29 Nov 2024
-
Net transactions value
-
-$7,754,546
-
Form type
-
4
-
Filing time
-
03 Dec 2024, 18:05:25 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+214,286 |
+211% |
$0.000000 |
316,009 |
29 Nov 2024 |
Direct |
F1 |
| transaction |
DRS |
Common Stock |
Tax liability |
$3,732,838 |
-107,358 |
-34% |
$34.77 |
208,651 |
29 Nov 2024 |
Direct |
F2 |
| transaction |
DRS |
Common Stock |
Options Exercise |
$0 |
+142,858 |
+68% |
$0.000000 |
351,509 |
29 Nov 2024 |
Direct |
F3 |
| transaction |
DRS |
Common Stock |
Tax liability |
$2,488,558 |
-71,572 |
-20% |
$34.77 |
279,937 |
29 Nov 2024 |
Direct |
F2 |
| transaction |
DRS |
Common Stock |
Sale |
$1,533,150 |
-45,000 |
-16% |
$34.07 |
234,937 |
02 Dec 2024 |
Direct |
F4, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DRS |
Performance Restricted Stock Unit |
Options Exercise |
$0 |
-214,286 |
-100% |
$0.000000 |
0 |
29 Nov 2024 |
Common Stock |
214,286 |
|
Direct |
F1 |
| transaction |
DRS |
Restricted Stock Unit |
Options Exercise |
$0 |
-142,858 |
-100% |
$0.000000 |
0 |
29 Nov 2024 |
Common Stock |
142,858 |
|
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: